β³ Fetching live dividend data...
Home βΊ Calculator βΊ ALBT Dividend Calculator 2026
Avalon GloboCare Corp. Β· NASDAQ
Price: $0.28 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ALBT β $130002177236468826112.00M in 10 years Β· $10,832,023,250,879,196,000,000,000.00/month
Avalon GloboCare Corp., along with its affiliated entities, manages and holds commercial real estate assets across both the United States and China. The company's service portfolio encompasses medical consulting, offering diverse solutions such as conducting research studies, delivering executive education, disseminating daily online briefings for executives, providing customized expert advice, and supplying management and consulting expertise, particularly in the fields of immunotherapy and in facilitating second opinions or referrals. Key therapeutic candidates include AVA-001, an anti-CD19 CAR-T therapy, which has successfully completed its initial human clinical trial for B-cell lymphoblastic leukemia that has recurred or is resistant to treatment (R/R). Another promising candidate, AVA-011, also a CAR-T cell therapy, has advanced through preclinical laboratory evaluations and is currently in the IND-enabling process development phase to produce cGMP-grade cells. The company is additionally engaged in the development of an RNA-based FASH-CARTM cell therapy platform. Furthermore, Avalon GloboCare is developing ACTEX, its proprietary clinical-grade, tissue-specific exosome. It collaborates with the Massachusetts Institute of Technology (MIT) to identify therapeutic and diagnostic targets using QTY-code protein design technology, which includes leveraging this technology to create a hemofiltration device for treating Cytokine Storm. The firm also partners with Arbele Limited for the co-development of advanced, transposon-based CAR-T, CAR-NK, and various other multi-target immune effector cell therapies. A strategic alliance with the University of Natural Resources and Life Sciences in Vienna, Austria, aims to develop an S-layer vaccine against SARS-CoV-2 (the virus responsible for COVID-19), designed for intranasal or oral delivery. Beyond these initiatives, the company is progressing with Avalon Cell and Avalon Rehab, and actively advocates for standardization within the exosome industry. Its corporate headquarters are situated in Freehold, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ALBT position with:
Real after-tax yield depends on where you live and how you hold ALBT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 709.22% | 706.42% | $70,922 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 602.84% | 600.04% | $60,284 / yr |
| πΊπΈ US Taxable (20%) | 20% | 567.38% | 564.58% | $56,738 / yr |
| π¬π§ UK ISA | 0% | 709.22% | 706.42% | $70,922 / yr |
| π¬π§ UK Taxable | 8.75% | 647.16% | 644.36% | $64,716 / yr |
| π¨π¦ TFSA | 0% | 709.22% | 706.42% | $70,922 / yr |
| π¨π¦ CA Taxable | 25% | 531.91% | 529.12% | $53,191 / yr |
| π¦πΊ Super (pension) | 15% | 602.84% | 600.04% | $60,284 / yr |
| π¦πΊ AU Taxable | 30% | 496.45% | 493.65% | $49,645 / yr |
| π©πͺ DE Taxable | 26.375% | 522.16% | 519.36% | $52,216 / yr |
| π«π· FR Taxable | 30% | 496.45% | 493.65% | $49,645 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ALBT pays quarterly β 4 times per year. Next ex-div: TBD.
How ALBT compares to typical Real Estate averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ALBT sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-29 | 200,000 | $0.28 | $56.4K | ||
| A-Award | 2026-06-29 | 200,000 | $0.28 | $56.4K | ||
| A-Award | 2026-06-29 | 100,000 | $0.28 | $28.2K | ||
| A-Award | 2026-06-29 | 400,000 | $0.28 | $112.8K | ||
| A-Award | 2026-06-29 | 400,000 | $0.28 | $112.8K | ||
| A-Award | 2026-06-29 | 100,000 | $0.28 | $28.2K | ||
| A-Award | 2025-12-12 | 1,364.84 | $1.50 | $2.0K | ||
| A-Award | 2021-05-01 | 8,000 | $10.20 | $81.6K | ||
| A-Award | 2022-11-01 | 8,000 | $4.30 | $34.4K | ||
| A-Award | 2022-05-01 | 8,000 | $5.30 | $42.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ALBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Avalon GloboCare Corp. (ALBT) is currently trading at $0.28, trading near its 52-week low. The current dividend yield is 709.22% based on an annual payout of $2.00 per share.
Avalon GloboCare Corp. (ALBT) is a real estate stock currently trading at $0.28 with a dividend yield of 709.22%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β